Atara’s Tab-cel Shows Promise for Treating Transplant-derived Lymphoma, Trial Data Shows
News
Atara Biotherapeutics’s investigative therapy Tab-cel (tabelecleucel) is a potentially safe and viable option to treat transplant-derived lymphoma, according to long-term data from two Phase 2 clinical trials. The new results will ... Read more